No retraction, correction or concern found when last checked on Oct 30, 2026.
Serum YKL-40 and colorectal cancer
C Cintin, J S Johansen, I J Christensen and 3 more
British Journal of Cancer · 1999
Abstract
YKL-40 is a mammalian member of the chitinase protein family. Although the function of YKL-40 is unknown, the pattern of its expression suggests a function in remodelling or degradation of extracellular matrix. High serum YKL-40 has been found in patients with recurrent breast cancer and has been related to short survival. In the present study we analysed YKL-40 in preoperative sera from patients with colorectal cancer and evaluated its relation to survival. Serum YKL-40 was determined by RIA in 603 patients. Survival after operation was registered, and median follow-up time was 61 months. Three hundred and forty patients died. Sixteen per cent of the patients with Dukes' A, 26% with Dukes' B, 19% with Dukes' C and 39% with Dukes' D had high serum YKL-40 levels (adjusted for age). Analysis of serum YKL-40 as a continuous variable showed an association between increased serum YKL-40 and short survival (P < 0.0001). Patients with high preoperative serum YKL-40 concentration had significantly shorter survival than patients with normal YKL-40 (HR = 1.7; 95% CI: 1.3-2.1, P < 0.0001). Multivariate Cox analysis including serum YKL-40, serum CEA, Dukes' stage, age and gender showed that high YKL-40 was an independent prognostic variable for short survival (HR = 1.4; 95% CI: 1.1-1.8, P = 0.007). These results suggest that YKL-40 may play an important role in tumour invasion.
References 27
- 1.
Bresalier R. S., Byrd J. C., Wang L., Raz A. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. Cancer Res. 1996;56(19):4354-4357.
Not in our library
- 2.
- 3.
Finlay I. G., McArdle C. S. Effect of occult hepatic metastases on survival after curative resection for colorectal carcinoma. Gastroenterology. 1983;85(3):596-599.
Not in our library
- 4.
Hu B., Trinh K., Figueira W. F., Price P. A. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem. 1996;271(32):19415-19420.
Not in our library10.1074/jbc.271.32.19415
- 5.
Jass J. R., Love S. B., Northover J. M. A new prognostic classification of rectal cancer. Lancet. 1987;1(8545):1303-1306.
Not in our library10.1016/s0140-6736(87)90552-6
- 6.
Johansen J. S., Cintin C., Jørgensen M., Kamby C., Price P. A. Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur J Cancer. 1995;31A(9):1437-1442.
Not in our library10.1016/0959-8049(95)00196-p
- 7.
Johansen J. S., Hvolris J., Hansen M., Backer V., Lorenzen I., Price P. A. Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol. 1996;35(6):553-559.
Not in our library10.1093/rheumatology/35.6.553
- 8.
Johansen J. S., Jensen H. S., Price P. A. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol. 1993;32(11):949-955.
Not in our library10.1093/rheumatology/32.11.949
- 9.
Johansen J. S., Williamson M. K., Rice J. S., Price P. A. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res. 1992;7(5):501-512.
Not in our library10.1002/jbmr.5650070506
- 10.
Kievit J., van de Velde C. J. Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation. A Markov analysis. Cancer. 1990;65(11):2580-2587.
Not in our library10.1002/1097-0142(19900601)65:11<2580::aid-cncr2820651131>3.0.co;2-i
- 11.
Kirkpatrick R. B., Emery J. G., Connor J. R., Dodds R., Lysko P. G., Rosenberg M. Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res. 1997;237(1):46-54.
Not in our library10.1006/excr.1997.3764
- 12.
Krause S. W., Rehli M., Kreutz M., Schwarzfischer L., Paulauskis J. D., Andreesen R. Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol. 1996;60(4):540-545.
Not in our library10.1002/jlb.60.4.540
- 13.
Lucha P. A., Rosen L., Olenwine J. A., Reed J. F., Riether R. D., Stasik J. J., Khubchandani I. T. Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma. Dis Colon Rectum. 1997;40(2):145-149.
Not in our library10.1007/bf02054978
- 14.
McArdle C. S., Hole D., Hansell D., Blumgart L. H., Wood C. B. Prospective study of colorectal cancer in the west of Scotland: 10-year follow-up. Br J Surg. 1990;77(3):280-282.
Not in our library10.1002/bjs.1800770314
- 15.
Morrison B. W., Leder P. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene. 1994;9(12):3417-3426.
Not in our library
- 16.
Newland R. C., Chapuis P. H., Smyth E. J. The prognostic value of substaging colorectal carcinoma. A prospective study of 1117 cases with standardized pathology. Cancer. 1987;60(4):852-857.
Not in our library10.1002/1097-0142(19870815)60:4<852::aid-cncr2820600422>3.0.co;2-5
- 17.
Nyirkos P., Golds E. E. Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period. Biochem J. 1990;269(1):265-268.
Not in our library10.1042/bj2690265
- 18.
Raz A., Zhu D. G., Hogan V., Shah N., Raz T., Karkash R., Pazerini G., Carmi P. Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis. Int J Cancer. 1990;46(5):871-877.
Not in our library10.1002/ijc.2910460520
- 19.
Rehli M., Krause S. W., Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics. 1997;43(2):221-225.
Not in our library10.1006/geno.1997.4778
- 20.
Royston P. Constructing time-specific reference ranges. Stat Med. 1991;10(5):675-690.
Not in our library10.1002/sim.4780100502
- 21.
Schoeppner H. L., Raz A., Ho S. B., Bresalier R. S. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer. 1995;75(12):2818-2826.
Not in our library10.1002/1097-0142(19950615)75:12<2818::aid-cncr2820751206>3.0.co;2-#
- 22.
Shackelton L. M., Mann D. M., Millis A. J. Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem. 1995;270(22):13076-13083.
Not in our library10.1074/jbc.270.22.13076
- 23.
Ståhle E., Glimelius B., Bergström R., Påhlman L. Preoperative prediction of outcome in patients with rectal and rectosigmoid cancer. Cancer. 1989;63(9):1831-1837.
Not in our library10.1002/1097-0142(19900501)63:9<1831::aid-cncr2820630929>3.0.co;2-#
- 24.
Virgo K. S., Vernava A. M., Longo W. E., McKirgan L. W., Johnson F. E. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA. 1995;273(23):1837-1841.
Not in our library
- 25.
Volck B., Price P. A., Johansen J. S., Sørensen O., Benfield T. L., Nielsen H. J., Calafat J., Borregaard N. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians. 1998;110(4):351-360.
Not in our library
- 26.
Wiggers T., Arends J. W., Schutte B., Volovics L., Bosman F. T. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer. 1988;61(2):386-395.
Not in our library10.1002/1097-0142(19880115)61:2<386::aid-cncr2820610231>3.0.co;2-j
- 27.
Wojciechowicz D. C., Park P. Y., Paty P. B. Beta 1-6 branching of N-linked carbohydrate is associated with K-ras mutation in human colon carcinoma cell lines. Biochem Biophys Res Commun. 1995;212(3):758-766.
Not in our library10.1006/bbrc.1995.2034
Cited by papers we hold 1
- Chitinase-3 like-protein-1 function and its role in diseases · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.